99 related articles for article (PubMed ID: 8230844)
1. A case-control study of risk factors for proliferative vitreoretinopathy in aphakia.
Nagasaki H; Ideta H; Mochizuki M; Shibata A
Jpn J Ophthalmol; 1993; 37(2):187-91. PubMed ID: 8230844
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.
Tseng W; Cortez RT; Ramirez G; Stinnett S; Jaffe GJ
Am J Ophthalmol; 2004 Jun; 137(6):1105-15. PubMed ID: 15183797
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of clinical factors that predispose patients to proliferative vitreoretinopathy in aphakia.
Nagasaki H; Ideta H; Uemura A; Morita H; Ito K; Yonemoto J
Retina; 1991; 11(2):204-7. PubMed ID: 1925083
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for retinal detachment after cataract surgery: a case-control study.
Tuft SJ; Minassian D; Sullivan P
Ophthalmology; 2006 Apr; 113(4):650-6. PubMed ID: 16581424
[TBL] [Abstract][Full Text] [Related]
5. Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy.
Rodriguez de la Rúa E; Pastor JC; Aragón J; Mayo-Iscar A; Martínez V; García-Arumí J; Giraldo A; Sanabria-Ruiz Colmenares MR; Miranda I
Curr Eye Res; 2005 Feb; 30(2):147-53. PubMed ID: 15814473
[TBL] [Abstract][Full Text] [Related]
6. [Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study].
Rodríguez de la Rúa E; Martínez V; Aragón J; Sanabria RM; Giraldo A; Mayo A; Pastor JC; Miranda I; García Arumí J
Arch Soc Esp Oftalmol; 2003 Feb; 78(2):91-7. PubMed ID: 12647249
[TBL] [Abstract][Full Text] [Related]
7. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
Kon CH; Occleston NL; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
9. [Clinical risk factors of vitreoretinal proliferations in rhegmatogenous retinal detachment].
Bonnet M
J Fr Ophtalmol; 1994; 17(8-9):530-40. PubMed ID: 7989662
[TBL] [Abstract][Full Text] [Related]
10. [Has the incidence of postoperative PVR in rhegmatogenous retinal detachment decreased?].
Bonnet M; Guenoun S; Yaniali A; Fleury J; Hajjar C; Dumas C; Duquesne N; Semiglia R
J Fr Ophtalmol; 1996; 19(11):696-704. PubMed ID: 9033891
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments.
Honavar SG; Goyal M; Majji AB; Sen PK; Naduvilath T; Dandona L
Ophthalmology; 1999 Jan; 106(1):169-76; discussion 177. PubMed ID: 9917800
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group.
Am J Epidemiol; 1993 Apr; 137(7):749-57. PubMed ID: 8484366
[TBL] [Abstract][Full Text] [Related]
13. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
[TBL] [Abstract][Full Text] [Related]
14. Capsule complication during cataract surgery: Retinal detachment after cataract surgery with capsule complication: Swedish Capsule Rupture Study Group report 4.
Jakobsson G; Montan P; Zetterberg M; Stenevi U; Behndig A; Lundström M
J Cataract Refract Surg; 2009 Oct; 35(10):1699-705. PubMed ID: 19781462
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative proliferative vitreoretinopathy in rhegmatogenous retinal detachment associated with stage B preoperative proliferative vitreoretinopathy: comparative results of trans-scleral retinopexy with diode laser or trans-pupillary retinopexy with argon laser].
Duquesne N; Fleury J; Bonnet M
J Fr Ophtalmol; 1998 Oct; 21(8):555-9. PubMed ID: 9833220
[TBL] [Abstract][Full Text] [Related]
16. [-Choroidal detachment associated with rhegmatogenous retinal detachment: a risk factor for postoperative PVR?].
Dumas C; Bonnet M
J Fr Ophtalmol; 1996; 19(6-7):455-63. PubMed ID: 8881408
[TBL] [Abstract][Full Text] [Related]
17. [Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery].
Lleó Pérez A ; Campos Fernández R ; López Santoveña F ; Sánchez Lorente G ; Hernández Martínez FJ ; Navarro Palop C
Arch Soc Esp Oftalmol; 2000 Nov; 75(11):741-750. PubMed ID: 11151263
[TBL] [Abstract][Full Text] [Related]
18. Aphakic retinal detachment.
Hawkins WR
Ophthalmic Surg; 1975; 6(2):66-74. PubMed ID: 1153162
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation--report no. 1.
Ahmadieh H; Moradian S; Faghihi H; Parvaresh MM; Ghanbari H; Mehryar M; Heidari E; Behboudi H; Banaee T; Golestan B;
Ophthalmology; 2005 Aug; 112(8):1421-9. PubMed ID: 15961159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
